What is the generic name?

ROLAPITANT

What is the Trade Name for ROLAPITANT?

Varubi

What are the Indications for ROLAPITANT?

• 1 INDICATIONS AND USAGE VARUBI ¬Æ is indicated in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. VARUBI is a substance P/neurokinin 1 (NK1) receptor antagonist indicated in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. ( 1 )

References: https://open.fda.gov/